rindopepimut

A cancer vaccine consisting of a human epidermal growth factor receptor variant III (EGFRvIIi)-specific peptide conjugated to the non-specific… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2016
012320002016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
INTRODUCTION Rindopepimut (CDX-110) is a peptide vaccine that targets epidermal growth factor receptor variant III (EGFRvIII), a… (More)
Is this relevant?
Review
2016
Review
2016
Glioblastoma is the most deadly primary brain tumor in adults and has long represented a therapeutic challenge. Disease… (More)
Is this relevant?
Highly Cited
2015
Highly Cited
2015
BACKGROUND The epidermal growth factor receptor variant III deletion mutation, EGFRvIII, is expressed in ∼30% of primary… (More)
Is this relevant?
2015
2015
G lioblastoma multiforme (GBM) is the most common primary brain tumor in adults. Standard therapy, including maximal surgical… (More)
Is this relevant?
Review
2015
Review
2015
Glioblastoma (GBM), the most common malignant primary tumor in adults, carries a dismal prognosis. Median overall survival (OS… (More)
Is this relevant?
Review
2014
Review
2014
Glioblastoma multiforme (GBM) is the most common and aggressive glial cell-derived primary tumor. Current standard of care for… (More)
Is this relevant?
Review
2014
Review
2014
Glioblastoma Multiforme (GBM) is the most common type of brain tumor and it is uniformly fatal. The community standard of… (More)
Is this relevant?
2013
2013
Glioblastoma, the most common primary malignant brain tumor, is among the most difficult cancers to treat. Despite the aggressive… (More)
Is this relevant?
Review
2012
Review
2012
Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults and is universally fatal. Despite surgical… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2010
2010
Celldex Therapeutics is developing rindopepimut (CDX-110), a 14-mer injectable peptide vaccine for the potential treatment of… (More)
Is this relevant?